Journal of Pharmaceutical Sciences

Cover image for Vol. 101 Issue 11

November 2012

Volume 101, Issue 11

Pages 4025–4366

  1. Mini Reviews

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
  2. Reviews

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. Active compounds release from semisolid dosage forms (pages 4032–4045)

      Anna Olejnik, Joanna Goscianska and Izabela Nowak

      Version of Record online: 8 AUG 2012 | DOI: 10.1002/jps.23289

    2. Formulation approaches to short interfering RNA and MicroRNA: Challenges and implications (pages 4046–4066)

      Diana Guzman-Villanueva, Ibrahim M. El-Sherbiny, Dea Herrera-Ruiz, Alexander V. Vlassov and Hugh D. C. Smyth

      Version of Record online: 28 AUG 2012 | DOI: 10.1002/jps.23300

  3. Clinical Trials and Translational Medicine Commentaries

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
  4. Perspectives

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. Impact of the pharmaceutical sciences on health care: A reflection over the past 50 years (pages 4075–4099)

      Malcolm Rowland, Christian R. Noe, Dennis A. Smith, G. T. Tucker, Daan J. A. Crommelin, Carl C. Peck, Mario L. Rocci Jr., Luc Besançon and Vinod P. Shah

      Version of Record online: 21 AUG 2012 | DOI: 10.1002/jps.23295

  5. Rapid Communication

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
  6. Biotechnology

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. Evaluation of effects of Fc domain high-mannose glycan on antibody stability (pages 4107–4117)

      Yuefeng Lu, Kimberly Westland, Yu-heng Ma and Himanshu Gadgil

      Version of Record online: 24 AUG 2012 | DOI: 10.1002/jps.23284

    2. Comparison of the structural stability and dynamic properties of recombinant anthrax protective antigen and its 2-fluorohistidine-labeled analogue (pages 4118–4128)

      Lei Hu, Sangeeta B. Joshi, Kiran K. Andra, Santosh V. Thakkar, David B. Volkin, James G. Bann and C. Russell Middaugh

      Version of Record online: 21 AUG 2012 | DOI: 10.1002/jps.23294

    3. Mechanistic complexity of subvisible particle formation: Links to protein aggregation are highly specific (pages 4140–4154)

      B. Robert Simler, Guodong Hui, Jennifer E. Dahl and Bernardo Perez-Ramirez

      Version of Record online: 21 AUG 2012 | DOI: 10.1002/jps.23299

  7. Drug Discovery Interface

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. In vitro measurement of drug efficiency index to aid early lead optimization (pages 4155–4169)

      Klara Valko, Elisabetta Chiarparin, Shenaz Nunhuck and Dino Montanari

      Version of Record online: 28 AUG 2012 | DOI: 10.1002/jps.23305

  8. Pharmaceutics, Preformulation and Drug Delivery

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. Degradation kinetics of an aspartyl-tripeptide-derived diketopiperazine under forced conditions (pages 4178–4190)

      Christin Brückner, Alfred Fahr, Diana Imhof and Gerhard K. E. Scriba

      Version of Record online: 16 AUG 2012 | DOI: 10.1002/jps.23272

    2. Improved intestinal absorption of a poorly water-soluble oral drug using mannitol microparticles containing a nanosolid drug dispersion (pages 4191–4200)

      Yukiko Nishino, Aya Kubota, Takanori Kanazawa, Yuuki Takashima, Tetsuya Ozeki and Hiroaki Okada

      Version of Record online: 2 AUG 2012 | DOI: 10.1002/jps.23278

    3. Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders (pages 4201–4213)

      Umesh S. Kestur, Duangporn Wanapun, Scott J. Toth, Lindsay A. Wegiel, Garth J. Simpson and Lynne S. Taylor

      Version of Record online: 30 JUL 2012 | DOI: 10.1002/jps.23280

  9. Pharmaceutical Nanotechnology

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. Surface-charge-dependent nanoparticles accumulation in inflamed skin (pages 4231–4239)

      Mona M. A. Abdel-Mottaleb, Brice Moulari, Arnaud Beduneau, Yann Pellequer and Alf Lamprecht

      Version of Record online: 1 AUG 2012 | DOI: 10.1002/jps.23282

    2. Scale-up of nanoemulsion produced by emulsification and solvent diffusion (pages 4240–4247)

      Khalil Mitri, Christine Vauthier, Nicolas Huang, Assia Menas, Catherine Ringard-Lefebvre, Cecilia Anselmi, Moncef Stambouli, Veronique Rosilio, Jean-Jacques Vachon and Kawthar Bouchemal

      Version of Record online: 8 AUG 2012 | DOI: 10.1002/jps.23291

  10. Pharmaceutical Technology

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. Analytical protein A chromatography as a quantitative tool for the screening of methionine oxidation in monoclonal antibodies (pages 4248–4257)

      Caroline Loew, Constanze Knoblich, Jürgen Fichtl, Nadja Alt, Katharina Diepold, Patrick Bulau, Pierre Goldbach, Michael Adler, Hanns-Christian Mahler and Ulla Grauschopf

      Version of Record online: 16 AUG 2012 | DOI: 10.1002/jps.23286

  11. Pharmacokinetics, Pharmacodynamics and Drug Metabolism

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. Comparative assessment of In Vitro–In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs (pages 4308–4326)

      Patrick Poulin, Cornelis E. C. A. Hop, Quynh Ho, Jason S. Halladay, Sami Haddad and Jane R. Kenny

      Version of Record online: 13 AUG 2012 | DOI: 10.1002/jps.23288

    2. Comparative pharmacokinetics studies of immediate- and modified-release formulations of glipizide in pigs and dogs (pages 4327–4336)

      Rajesh Kulkarni, Nathan Yumibe, Zhongyi Wang, Xin Zhang, Cheng Cai Tang, Kenneth Ruterbories, Amy Cox, Robyn McCain and Gregory T. Knipp

      Version of Record online: 16 AUG 2012 | DOI: 10.1002/jps.23292

    3. Pharmacokinetic and pharmacodynamic modeling for the effect of sodium–glucose cotransporter inhibitors on blood glucose level and renal glucose excretion in db/db mice (pages 4347–4356)

      Koji Yamaguchi, Motohiro Kato, Kazuharu Ozawa, Takahiro Kawai, Tatsuo Yata, Yoshinori Aso, Masaki Ishigai and Sachiya Ikeda

      Version of Record online: 21 AUG 2012 | DOI: 10.1002/jps.23302

  12. Notes

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
  13. Erratum

    1. Top of page
    2. Mini Reviews
    3. Reviews
    4. Clinical Trials and Translational Medicine Commentaries
    5. Perspectives
    6. Rapid Communication
    7. Biotechnology
    8. Drug Discovery Interface
    9. Pharmaceutics, Preformulation and Drug Delivery
    10. Pharmaceutical Nanotechnology
    11. Pharmaceutical Technology
    12. Pharmacokinetics, Pharmacodynamics and Drug Metabolism
    13. Notes
    14. Erratum
    1. You have free access to this content

SEARCH

SEARCH BY CITATION